Author

Kun-Ming Chen

Pennsylvania State UniversityORCID 0000-0002-3820-6149Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Kun-Ming Chen1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Ashley Elizabeth ShayiD· 1 shared Bin QiaoiD· 1 shared Bo Ni· 1 shared Boyang Fu· 1 shared Chenyang Meng· 1 shared Dongxiao SuniD· 1 shared Girish Halemirle RajacharyaiD· 1 shared Guangcong SheniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ashley Elizabeth ShayORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedDec 31, 2025

Adaptation to cystine limitation stress confers a targetable lipid metabolism vulnerability in pancreatic ductal adenocarcinoma

Yunzhan Li, Zekun Li, Qin Li…·Shengyu Yang

This study shows that adaptation to cystine limitation stress in PDAC promotes tumor growth via lipid metabolism reprogramming, and lomitapide can inhibit this process and enhance chemotherapy.

7 citations

humanbulk RNA-seq

𝕏 PostBluesky